Financial Interest Index
As a provider accredited by the Accreditation council for Continuing Medical Education, ASCRS must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly provided activities.
All individuals participating in an activity designated for CME credit must disclose any financial interest or relationship with an ineligible company that produces, markets, sells, resells, or distributes ophthalmic products/devices/drugs or services used on or by patients that are discussed in an educational presentation or lack thereof. Financial interest can include such things as grants or research support, consultant, stockholder, member of speaker’s bureau, et.
The intent of this disclosure is not to disqualify anyone from participating, but to provide the program committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Interest Index provides information to attendees, so they can make their own judgement regarding the interest or relationship and the materials presented. A complete listing of relations disclosed, and their corresponding codes are below.
Scottsdale, AZ Dinner
Cathleen McCabe, MD is a consultant for Alcon, Allergan, Bausch and Lomb, Ivantis, Sight Sciences, and Zeiss. She receives lecture fees from Alcon, Allergan, Bausch and Lomb, Ivantis and Sight Sciences. She receives research support from Alcon, Glaukos, Ivantis, and Sun Pharmaceuticals.
Manjool Shah, MD is a consultant for Abbvie, Alcon, Glauckos, and Nova.
Mitchell Weikert, MD is a consultant for Alcon and Zeiss.
Kristine Coan and Carrie Braden, ASCRS Staff, have no financial interests.
All of the relevant financial relationships for these individuals have been mitigated.
New York, New York Dinner
Vance Thompson, MD is a consultant for Alcon, Bausch and Lomb, Carl Zeiss Meditec, Glaukos, Johnson and Johnson, RxSight, Staar Surgical and Tarsus. Receives research/grant support from Alcon, Bausch and Lomb, Carl Zeiss Meditec, Glaukos, Johnson and Johnson, RxSight and Staar Surgical. Recieves Lecture fees from Alcon, Bausch and Lomb, Carl Zeiss Meditec, Johnson and Johnson and RxSight. Investor in RxSight and Tarsus.
Elizabeth Yeu, MD recieves research/grant support from Alcon and Tarsus. Is a consultant for Bausch and Lomb, Glaukos, Johnson and Johnson, Sight Sciences, Staar Surgical, Tarsus and Zeiss. Investor in Staar Surgical and Tarsus.
Robert Weinstock, MD is a consultant for Alcon, Bausch and Lomb, Johnson and Johnson Vision. Receives lecture fees from Bausch and Lomb and Johnson and Johnson Vision. Investor in RxSight.
Eric Donnenfeld, MD is a consultant for Alcon, Bausch and Lomb, Johnson and Johnson Vision. Receives lecture fees from Bausch and Lomb and Johnson and Johnson Vision. Investor in RxSight.
Leela Raju, MD has no relevant financial relationships.
Mitchell Weikert, MD is a consultant for Alcon Surgical, Inc. and Carl Zeiss Meditec, Inc.
Kristine Coan and Carrie Braden, ASCRS Staff, have no financial interests.
All of the relevant financial relationships for these individuals have been mitigated.
New York, New York YES Dinner
Richard Tipperman, MD is a consultant for Alcon Laboratories.
Leela Raju, MD has no relevant financial relationships.
Aakriti Garg Shukla, MD is a consultant for Allergan.
Brenton Finklea, MD is a consultant for Alcon.
Mitchell Weikert, MD is a consultant for Alcon Surgical, Inc. and Carl Zeiss Meditec, Inc.
Kristine Coan, Sheela Patel and Carrie Braden, ASCRS Staff, have no financial interests.
All of the relevant financial relationships for these individuals have been mitigated.